SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-097946
Filing Date
2019-04-04
Accepted
2019-04-04 16:46:03
Documents
8
Period of Report
2019-04-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d697619d8k.htm 8-K 23091
2 EX-1.1 d697619dex11.htm EX-1.1 271517
3 EX-4.1 d697619dex41.htm EX-4.1 90045
4 EX-5.1 d697619dex51.htm EX-5.1 14201
5 EX-99.1 d697619dex991.htm EX-99.1 8721
6 GRAPHIC g697619g01l69.jpg GRAPHIC 12535
7 GRAPHIC g697619g0404120451849.jpg GRAPHIC 4041
8 GRAPHIC g697619g31m04.jpg GRAPHIC 3497
  Complete submission text file 0001193125-19-097946.txt   436826
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617- 531-2130
AVEO PHARMACEUTICALS INC (Filer) CIK: 0001325879 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34655 | Film No.: 19732687
SIC: 2834 Pharmaceutical Preparations